Of the nine MS risk genes tested, five were significantly responsive to serum depletion in males, and none in females (CD40, ADCY3, ZC3HAV1, CLECL1 and IKZF3; Figure 6, p < 0.05). This evidence concerns the gene CD40 and myeloid sarcoma.